Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
Sweden · Delayed Price · Currency is SEK 0.1805
-0.0045 (-2.43%)
At close: Aug 6, 2026
Inhalation Sciences Sweden AB Earnings Call Transcripts
Fiscal Year 2025
-
Q2 saw FDA approval to publish DissolvIt study data, a SEK 10 million rights issue, and a new CCO. R&D costs dropped over 50% year-over-year, with a strong sales pipeline and upcoming awareness campaign leveraging regulatory trends.